Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Announces Q3 results (Standalone & Consolidated), Limited Review Report (Standalone & Consolidated) & Results Press Release for the Quarter ended December 31, 2016

 Fortis Healthcare Ltd has announced the following results for the quarter ended December 31, 2016:The Unaudited Standalone results for the Quarter ended December 31, 2016The Company has posted a net loss of Rs. (614.70) million for the quarter ended December 31, 2016 where as the same was at net loss of Rs. (143.30) million for the quarter ended December 31, 2015. Total Income is Rs. 1999.70 million for the quarter ended December...
14-02-2017
Bigul

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fortis Healthcare Holdings Pvt Ltd
07-02-2017
Bigul

Q3 results on Feb 14, 2017

 Fortis Healthcare Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 14, 2017, inter alia, to consider and approve the Un-audited Financial Results for the quarter and period ended on December 31, 2016 (Q3).Further, the trading window of the Company for dealing in securities of the Company will remain closed from February 07, 2017 to February 16, 2017 (both days inclusive).
06-02-2017
Bigul

Shareholding for the Period Ended January 28, 2017

 Fortis Healthcare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended January 28, 2017. For more details, kindly Click here
30-01-2017
Bigul

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Standard Chartered Private Equity Mauritius III Ltd
25-01-2017
Bigul

Fortis Hospital in Navi Mumbai asked to vacate

 Fortis Healthcare Ltd has informed BSE that a Navi Mumbai hospital operated and controlled by subsidiary Hiranandani Healthcare, has been asked to vacate premises by February 18 by the Navi Mumbai Municipal Corporation (NMMC). The reasons are as yet unclear, although Fortis says it is examining its options - including challenging the order - to address the issue.
20-01-2017
Bigul

Updates on Subsidiary

 Fortis Healthcare Ltd has informed BSE that one of the Company's facility (Hospital) operated and controlled by one of the Subsidiary Hiranandani Healthcare Private Limited has received an order on January 18, 2017 from Navi Mumbai Municipal Corporation (NMMC) to vacate the premises within one month. Further the Company has informed that, the management of the HHPL and the Company are evaluating all possible legal remedies available including to...
20-01-2017
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fortis Healthcare Holdings Pvt Ltd
18-01-2017
Bigul

No stay on Fortis stake sale plan yet

 Daiichi Sankyo had sought a stay on plans by Malvinder and Shivinder Singh to sell over 26% in the healthcare firm
17-01-2017
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fortis Healthcare Holdings Pvt Ltd
16-01-2017
Next Page
Close

Let's Open Free Demat Account